Year Book of Rheumatology, Arthritis, and Musculoskeletal Disease
2003
|
Revised edition
Mosby (Verlag)
978-0-323-01521-9 (ISBN)
Mosby (Verlag)
978-0-323-01521-9 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Aims to bring you abstracts of the articles that reported the developments in rheumatology, arthritis, and musculoskeletal disease, selected from more than 500 journals. This book features commentaries that evaluate the clinical importance of each article and discuss its application to your practice.
"The Year Book of Rheumatology, Arthritis, and Musculoskeletal Disease" brings you abstracts of the articles that reported the year's breakthrough developments in rheumatology, arthritis, and musculoskeletal disease, carefully selected from more than 500 journals worldwide. Expert commentaries evaluate the clinical importance of each article and discuss its application to your practice. There's no faster or easier way to stay informed! This year's edition gives readers the latest information on links between Cox-2 inhibitors and increased risk of cardiovacular disease, acetaminophen as initial therapy for osteoarthritis, difference between men and women with giant cell arteritis, use of cytokine levels to predict length of treatment for patients with giant cell arteritis, work-related musculoskeletal syndromes, and oral tolerance as possible therapy for autoimmune disease. "The Year Book of Rheumatology, Arthritis, and Musculoskeletal Disease" publishes annually in February.
"The Year Book of Rheumatology, Arthritis, and Musculoskeletal Disease" brings you abstracts of the articles that reported the year's breakthrough developments in rheumatology, arthritis, and musculoskeletal disease, carefully selected from more than 500 journals worldwide. Expert commentaries evaluate the clinical importance of each article and discuss its application to your practice. There's no faster or easier way to stay informed! This year's edition gives readers the latest information on links between Cox-2 inhibitors and increased risk of cardiovacular disease, acetaminophen as initial therapy for osteoarthritis, difference between men and women with giant cell arteritis, use of cytokine levels to predict length of treatment for patients with giant cell arteritis, work-related musculoskeletal syndromes, and oral tolerance as possible therapy for autoimmune disease. "The Year Book of Rheumatology, Arthritis, and Musculoskeletal Disease" publishes annually in February.
| Erscheint lt. Verlag | 27.11.2003 |
|---|---|
| Reihe/Serie | Year Books |
| Verlagsort | London |
| Sprache | englisch |
| Gewicht | 650 g |
| Themenwelt | Schulbuch / Wörterbuch ► Lexikon / Chroniken |
| Medizinische Fachgebiete ► Innere Medizin ► Rheumatologie | |
| ISBN-10 | 0-323-01521-2 / 0323015212 |
| ISBN-13 | 978-0-323-01521-9 / 9780323015219 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Das Wichtigste für Klinik und Praxis
Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 49,90
Information für Erkrankte, Angehörige und Betreuende
Buch | Softcover (2023)
Springer (Verlag)
CHF 32,15
